Concepedia

Mathieu Le Gars

ML

25

Publications

5.6K

Citations

20

H-Index

2012

Active since

Affiliations

Janssen (Netherlands)(Current)

Janssen (Belgium)

Beth Israel Deaconess Medical Center

South African Medical Research Council

Ragon Institute of MGH, MIT and Harvard

Mathieu Le Gars is an author at Janssen (Netherlands) specializing in immunology, medicine, and vaccination.

Top concepts

Publications per year

2012–2023

25

Publications

25

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2021 · 2.5K citations · Full text

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Galit Alter, Jingyou Yu, Jinyan Liu et al. · Nature · 2021 · 342 citations · Full text

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Kathryn E. Stephenson, Mathieu Le Gars, Jerald Sadoff et al. · JAMA · 2021 · 313 citations · Full text

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2022 · 246 citations · Full text

Rows per page

1–5 of 25